CTSO Cytosorbents Corporation

Fundamentals / CIK 0001175151 / USD

Cytosorbents Corporation reported $37.46M in revenue and a net loss of $17.50M for the trailing twelve months ended September 30, 2026 (up 2.6% year over year), with a 72.9% gross margin and a -30.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CTSO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$46.01M$23.00M$0-$34.35MFY 2016 Revenue: $9.53MFY 2016 Net Income: -$11.76M2016FY 2017 Revenue: $15.15MFY 2017 Net Income: -$8.46M2017FY 2018 Revenue: $22.50MFY 2018 Net Income: -$17.21M2018FY 2019 Revenue: $24.95MFY 2019 Net Income: -$19.27M2019FY 2020 Revenue: $41.00MFY 2020 Net Income: -$7.84M2020FY 2021 Revenue: $43.17MFY 2021 Net Income: -$24.56M2021FY 2022 Revenue: $34.69MFY 2022 Net Income: -$32.81M2022FY 2023 Revenue: $31.08MFY 2023 Net Income: -$29.25M2023FY 2024 Revenue: $35.59MFY 2024 Net Income: -$20.72M2024FY 2025 Revenue: $37.06MFY 2025 Net Income: -$8.20M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $37.06M $35.59M $31.08M $34.69M $43.17M $41.00M $24.95M $22.50M $15.15M $9.53M
Cost of Revenue $10.57M $10.71M $9.13M $13.96M $11.05M $11.05M $7.36M $7.49M $5.52M $3.95M
Gross Profit $26.49M $24.89M $21.95M $20.73M $32.12M $29.95M $17.59M $15.01M $9.63M $5.57M
Research & Development -- -- $15.73M $15.12M $16.38M $8.81M $12.09M $7.72M $3.22M $4.07M
Selling, General & Admin $35.65M $33.73M $38.31M $34.29M $35.75M $28.46M $22.01M $20.87M $14.91M $11.81M
Total Operating Expenses $41.24M $41.34M $53.90M $52.25M $54.86M $40.32M $36.56M $30.60M $19.47M $17.07M
Operating Income -$14.75M -$16.45M -$31.95M -$31.52M -$22.74M -$10.37M -$18.97M -$15.58M -$9.84M -$11.49M
EBITDA -$13.52M -$15.12M -$30.49M -$30.64M -$22.01M -$9.71M -$18.39M -$15.19M -$9.62M -$11.33M
Income Before Tax -$8.60M -$22.41M -$30.06M -$33.91M -$25.29M -$8.96M -$20.36M -$17.83M -$9.14M -$12.08M
Income Tax Expense -$401K -$1.69M -$814K -$1.09M -$736K -$1.13M -$1.09M -$620K -$677K -$319K
Net Income -$8.20M -$20.72M -$29.25M -$32.81M -$24.56M -$7.84M -$19.27M -$17.21M -$8.46M -$11.76M
Basic EPS -$2.60 -$7.60 -$13.00 -$15.00 -$11.40 -$4.00 -$12.00 -$11.20 -$6.40 -$9.20
Diluted EPS -$2.60 -$7.60 -$13.00 -$15.00 -$11.40 -$4.00 -$12.00 -$11.20 -$6.40 -$9.20
Basic Shares Outstanding 3.1M 2.7M 2.2M 2.2M 2.2M 1.9M 1.6M 1.5M 1.4M 1.3M
Diluted Shares Outstanding 3.1M 2.7M 2.2M 2.2M 2.2M 1.9M 1.6M 1.5M 1.4M 1.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $9.73M $9.63M $8.86M $9.23M $9.48M $9.62M $8.73M $9.15M
Cost of Revenue $2.40M $2.58M $2.73M $2.43M $2.82M $2.80M $2.52M $2.90M
Gross Profit $7.33M $7.05M $6.13M $6.80M $6.67M $6.81M $6.21M $6.25M
Research & Development $1.15M $1.45M $1.02M -- $918K $1.26M $1.66M --
Selling, General & Admin $7.10M $7.96M $8.15M $9.44M $8.61M $9.17M $8.43M $7.63M
Total Operating Expenses $8.50M $9.69M $9.17M $11.19M $9.53M $10.43M $10.10M $9.65M
Operating Income -$1.17M -$2.64M -$3.04M -$4.38M -$2.86M -$3.62M -$3.89M -$3.40M
EBITDA -$769K -$2.28M -$2.69M -$4.09M -$2.57M -$3.33M -$3.52M -$3.24M
Income Before Tax -$2.05M -- -- -$5.50M -$3.57M -- -$1.48M -$9.26M
Income Tax Expense $0 $0 $0 $0 -$401K $0 $0 -$1.69M
Net Income -$2.05M -$4.57M -$5.38M -$5.50M -$3.17M $1.95M -$1.48M -$7.57M
Basic EPS -$0.65 -$1.46 -$1.72 -- -$1.01 $0.60 -$0.40 --
Diluted EPS -$0.65 -$1.46 -$1.72 -- -$1.01 $0.60 -$0.40 --
Basic Shares Outstanding 3.1M 3.1M 3.1M -- 3.1M 3.1M 3.0M --
Diluted Shares Outstanding 3.1M 3.1M 3.1M -- 3.1M 3.4M 3.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Sep 30 Jun 30 Mar 31 Dec 31 Sep 30 Jun 30 Mar 31 Dec 31
Cash & Cash Equivalents $6.25M $3.28M $5.69M $8.46M $8.61M $14.13M $8.36M $13.15M $19.05M $22.14M
Cash & Short-Term Investments $6.25M $3.28M $5.69M $8.46M $8.61M $14.13M $8.36M $13.15M $19.05M $22.14M
Accounts Receivable, Net $7.55M $7.32M $6.63M $7.82M $6.77M $6.06M $6.18M $7.02M $5.53M $5.66M
Inventory $5.28M $2.73M $3.25M $4.32M $3.74M $3.38M $2.98M $2.05M $1.73M $3.46M
Total Current Assets $20.63M $21.60M $16.60M $21.96M $19.99M $25.40M $19.26M $23.64M $28.16M $33.76M
Property, Plant & Equipment, Net $7.82M $9.00M $9.27M $9.42M $9.75M $10.06M $10.28M $10.50M $10.70M $10.74M
Intangible Assets $3.23M $3.72M -- -- -- $3.91M -- -- -- $4.39M
Other Non-Current Assets $53K $50K $3.80M $3.77M $3.92M $3.96M $4.15M $4.28M $4.45M $4.44M
Total Non-Current Assets $23.55M $25.77M $31.21M $31.47M $27.08M $27.56M $28.31M $28.80M $29.30M $29.47M
Total Assets $44.18M $47.37M $47.80M $53.43M $47.07M $52.96M $47.58M $52.44M $57.46M $63.23M
Accounts Payable $2.87M $3.34M $2.34M $3.05M $2.40M $3.80M $3.44M $2.84M $2.99M $1.66M
Short-Term Debt -- -- -- -- $2.50M $2.50M $833K -- -- --
Deferred Revenue (Current) $182K $596K -- -- -- $1.38M -- -- -- $1.52M
Other Current Liabilities -- $812K -- -- -- $992K -- -- -- --
Total Current Liabilities $9.71M $9.82M $8.28M $9.64M $12.72M $14.04M $11.67M $9.99M $9.45M $9.71M
Long-Term Debt $16.67M $14.00M $13.81M $13.67M $1.93M $2.54M $4.20M $5.02M $5.01M $5.00M
Total Non-Current Liabilities $28.57M $26.44M $26.37M $26.35M $14.72M $15.44M $17.09M $18.00M $18.07M $18.14M
Total Liabilities $38.28M $36.27M $34.66M $36.00M $27.44M $29.48M $28.76M $27.98M $27.52M $27.86M
Total Debt (incl. Leases) $29.11M $26.89M $26.81M $26.77M $17.61M $18.31M $18.04M $18.11M $18.18M $18.25M
Common Stock $3.0K $55K $54K $54K $54K $54K $44K $44K $44K $44K
Retained Earnings -$312.2M -$304.0M -$296.4M -$293.7M -$289.4M -$283.3M -$277.1M -$268.0M -$261.4M -$254.0M
Accumulated Other Comp. Income -$2.98M $4.25M -$157K $2.17M $1.75M $529K $2.98M $1.33M $1.72M $2.33M
Total Stockholders' Equity $5.90M $11.11M $13.38M $17.43M $19.63M $23.48M $18.81M $24.46M $29.94M $35.37M
Total Equity $5.90M $11.11M $13.38M $17.43M $19.63M $23.48M $18.81M $24.46M $29.94M $35.37M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.21M $4.41M $4.81M $6.25M $7.54M $10.20M $11.59M $3.28M
Cash & Short-Term Investments $4.21M $4.41M $4.81M $6.25M $7.54M $10.20M $11.59M $3.28M
Accounts Receivable, Net $7.07M $6.79M $7.15M $7.55M $7.43M $7.74M $7.67M $7.32M
Inventory $3.23M $3.69M $4.48M $5.28M $4.00M $3.71M $3.02M $2.73M
Total Current Assets $15.44M $15.74M $17.76M $20.63M $21.31M $22.99M $25.41M $21.60M
Property, Plant & Equipment, Net $6.89M $7.17M $7.51M $7.82M $8.19M $8.47M $8.72M $9.00M
Intangible Assets $2.80M $2.86M $2.95M $3.23M $3.59M $3.74M $3.70M $3.72M
Other Non-Current Assets $52K $53K $52K $53K $3.65M $3.79M $3.76M $50K
Total Non-Current Assets $21.72M $22.22M $22.80M $23.55M $24.44M $25.00M $25.37M $25.77M
Total Assets $37.16M $37.96M $40.56M $44.18M $45.75M $47.99M $50.78M $47.37M
Accounts Payable $2.77M $2.00M $3.13M $2.87M $3.04M $3.39M $3.33M $3.34M
Short-Term Debt $17.52M $14.15M $6.65M -- -- -- -- --
Deferred Revenue (Current) $824K $1.13M $34K $182K $403K $361K $546K $596K
Other Current Liabilities -- -- -- -- -- $965K $797K $812K
Total Current Liabilities $28.03M $24.02M $16.30M $9.71M $10.11M $9.84M $9.74M $9.82M
Long-Term Debt $0 $3.09M $10.31M $16.67M $14.57M $14.38M $14.19M $14.00M
Total Non-Current Liabilities $11.44M $14.69M $22.07M $28.57M $26.62M $26.56M $26.50M $26.44M
Total Liabilities $39.47M $38.71M $38.37M $38.28M $36.73M $36.40M $36.24M $36.27M
Total Debt (incl. Leases) $29.57M $29.43M $29.28M $29.11M $27.14M $27.06M $26.98M $26.89M
Common Stock $3.0K $63K $63K $3.0K $63K $63K $63K $55K
Retained Earnings -$324.2M -$322.2M -$317.6M -$312.2M -$306.7M -$303.5M -$305.5M -$304.0M
Accumulated Other Comp. Income -$277K -$593K -$1.85M -$2.98M -$3.84M -$3.96M $1.52M $4.25M
Total Stockholders' Equity -$2.31M -$751K $2.19M $5.90M $9.02M $11.59M $14.54M $11.11M
Total Equity -$2.31M -$751K $2.19M $5.90M $9.02M $11.59M $14.54M $11.11M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$8.20M -$20.72M -$29.25M -$32.81M -$24.56M -$7.84M -$19.27M -$17.21M -$8.46M -$11.76M
Depreciation & Amortization $1.23M $1.33M $1.46M $883K $732K $661K $582K $391K $218K $162K
Stock-Based Compensation $2.77M $3.76M $4.16M $3.42M $4.02M $3.51M $1.67M $4.44M $3.31M $2.76M
Change in Receivables $423K -$1.72M -$246K -$1.29M $421K -$327K -$642K -$1.85M -$649K -$890K
Change in Inventory -$2.54M $500K $183K $945K -$2.35M -$462K -$1.28M -$57K $57K $340K
Operating Cash Flow -$12.38M -$14.43M -$21.66M -$28.23M -$14.01M -$5.61M -$16.76M -$10.84M -$6.46M -$6.73M
Capital Expenditure -$164K -$284K -$538K -$6.09M -$3.64M -$708K -$698K -$672K -$991K -$141K
Free Cash Flow -$12.54M -$14.71M -$22.19M -$34.32M -$17.65M -$6.32M -$17.46M -$11.51M -$7.45M -$6.87M
Purchases of Investments -- -- -- -- -- -- -- -- $0 $0
Sales & Maturities of Investments -- -- -- -- -- -- -- $0 $0 $2.19M
Investing Cash Flow -$415K -$669K -$936K -$6.46M -$4.28M -$1.68M -$1.52M -$1.52M -$1.68M $1.60M
Common Stock Issued -- -- -- -- $27.20M $27.20M $14.13M $10.30M $10.30M --
Financing Cash Flow $9.31M $9.33M $14.47M $4.96M $715K $66.35M $8.18M $17.47M $20.12M $5.06M
Net Change in Cash -$1.99M -$5.85M -$8.22M -$29.99M -$17.60M $59.19M -$10.14M $5.05M $12.08M -$72K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.06M -$4.57M -$5.38M -$5.50M -$3.17M $1.95M -$1.48M -$7.57M
Depreciation & Amortization $400K $360K $350K $295K $290K $280K $369K $154K
Stock-Based Compensation $291K $368K $544K $886K $488K $571K $818K $920K
Change in Receivables -$326K $67K $310K -$137K $303K $337K -$80K -$1.09M
Change in Inventory $484K $789K $723K -$1.29M -$322K -$726K -$199K $347K
Operating Cash Flow -$267K -$583K -$1.16M -$4.83M -$2.58M -$1.51M -$3.47M -$2.34M
Capital Expenditure -$20K -$14K -$11K -$108K -$17K -$37K -$2.0K -$69K
Free Cash Flow -$287K -$597K -$1.17M -$4.93M -$2.59M -$1.55M -$3.47M -$2.41M
Investing Cash Flow -$4.0K $7.0K -$46K -$291K $55K -$132K -$47K -$124K
Financing Cash Flow -- -- -- $2.48M $0 $0 $6.83M $167K
Net Change in Cash -$208K -$400K -$1.44M -$1.29M -$2.67M -$1.38M $3.35M -$2.40M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 71.5% 69.9% 70.6% 59.8% 74.4% 73.0% 70.5% 66.7% 63.6% 58.5%
Operating Margin -39.8% -46.2% -102.8% -90.9% -52.7% -25.3% -76.0% -69.3% -65.0% -120.6%
Net Profit Margin -22.1% -58.2% -94.1% -94.6% -56.9% -19.1% -77.2% -76.5% -55.8% -123.5%
Return on Equity (ROE) -138.9% -186.5% -124.6% -92.8% -39.2% -9.9% -563.6% -101.6% -82.4% -879.5%
Return on Assets (ROA) -18.6% -43.7% -55.2% -51.9% -27.4% -8.7% -70.4% -50.3% -35.1% -121.3%
Current Ratio 2.13x 2.20x 1.81x 3.48x 4.70x 8.12x 2.10x 4.09x 2.64x 1.83x
Quick Ratio 1.58x 1.92x 1.57x 3.12x 4.35x 7.86x 1.89x 3.97x 2.54x 1.63x
Debt to Equity 4.93x 2.42x 0.78x 0.52x 0.22x 0.01x 4.72x 0.67x 0.97x 3.67x
Revenue Growth (YoY) +4.1% +14.5% -10.4% -19.6% +5.3% +64.4% +10.9% +48.5% +59.0% +98.8%
Gross Profit Growth (YoY) +6.4% +13.4% +5.9% -35.4% +7.2% +70.3% +17.1% +55.9% +72.8% +116.1%
5Y Revenue / Share Growth -43.6% -15.5% -5.0% +45.1% +165.7% +448.6% +169.8% +185.5% +202368.1% +4159393.4%
10Y Revenue / Share Growth +209.3% +128.1% +171.3% +293678.5% +11053702.9% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 72.9% 71.6% 71.0% 71.5% 70.2% 67.9% 68.6% 69.9%
Operating Margin -30.0% -34.7% -37.4% -39.8% -37.2% -43.6% -44.4% -46.2%
Net Profit Margin -46.7% -50.0% -32.5% -22.1% -27.8% -27.3% -45.6% -58.2%
Return on Equity (ROE) -- -- -551.5% -138.9% -113.8% -85.2% -110.8% -186.5%
Return on Assets (ROA) -47.1% -49.0% -29.8% -18.6% -22.4% -20.6% -31.7% -43.7%
Current Ratio 0.55x 0.66x 1.09x 2.13x 2.11x 2.34x 2.61x 2.20x
Quick Ratio 0.44x 0.50x 0.81x 1.58x 1.71x 1.96x 2.30x 1.92x
Debt to Equity -- -- 13.34x 4.93x 3.01x 2.34x 1.85x 2.42x
Revenue Growth (YoY) +2.6% +0.2% +1.6% +0.9% +10.1% +8.8% -2.9% +5.6%
Gross Profit Growth (YoY) +9.9% +3.4% -1.2% +8.8% +26.8% +4.8% -9.7% +17.8%
Net Income Growth (YoY) -- -334.7% -- -- -- -- -- --
EPS Growth (YoY) -- -343.3% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001175151) · from December 31, 1997 Data through September 30, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal